Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Recruiting now
Conditions studied: Breast Cancer, Molecular Pathway Deregulation, Treatment
In brief
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
Key facts
- Study ID
- NCT06830590
- Run by
- Liaquat University of Medical & Health Sciences
- People needed
- 300
- Starts
- 2016-02-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-08-13
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC
You may not qualify if…
- patients received pre-operative chemotherapy or radiotherapy
Where it is running
- Binafsha M Syed — Jamshoro, Pakistan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.